applying molecular understanding of dlbcl to management strategies
Published 4 years ago • 48 plays • Length 3:04Download video MP4
Download video MP3
Similar videos
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
7:16
changes in the classification of dlbcl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
3:31
a summary of the prognostic factors that can influence the outcomes of anti-cd19 car-t in r/r dlbcl
-
52:32
what is a clinical trial management system (ctms)?
-
12:52
diagnostic pathologist's approach to lymphoid prolif video
-
38:25
optimizing patient blood management the role of the laboratory
-
2:53
autohct in dlbcl in the car-t era
-
1:15
personalized medicine for dlbcl
-
1:21
novel approaches to harnessing the immune system in lymphoma
-
3:07
the role of bridging and timing in car-t
-
0:42
targeted therapies for dlbcl treatment
-
1:20
improving patient outcomes in ctcl: clinical collaboration and novel agents
-
2:41
an overview of the latest advances in hematology
-
1:35
update on phase i study of plamotamab in r/r nhl
-
3:21
safety management of car-t cell therapy in dlbcl
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
2:08
impact of bridging therapy on the outcomes of patients with r/r myeloma treated with ide-cel
-
0:50
management of variant acute promyelocytic leukemia
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml